Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5448)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2020 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T. Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol 2020; 12(8): 903-917 [PMID: 32879667 DOI: 10.4251/wjgo.v12.i8.903] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i8/903.htm |
| Number | Citing Articles |
| 1 |
Roxan F. C. P. A. Helderman, Daan R. Löke, Pieter J. Tanis, Jurriaan B. Tuynman, Wim Ceelen, Ignace H. de Hingh, Kurt van der Speeten, Nicolaas A. P. Franken, Arlene L. Oei, H. Petra Kok, Johannes Crezee. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges. Cancers 2021; 13(14): 3430 doi: 10.3390/cancers13143430
|
| 2 |
Megan M. Harper, Joseph Kim, Prakash K. Pandalai. Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies. Journal of Clinical Medicine 2022; 11(10): 2840 doi: 10.3390/jcm11102840
|
| 3 |
Martin Hübner, Kurt van Der Speeten, Kim Govaerts, Ignace de Hingh, Laurent Villeneuve, Shigeki Kusamura, Olivier Glehen. 2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer. Annals of Surgical Oncology 2024; 31(1): 567 doi: 10.1245/s10434-023-14368-5
|
| 4 |
Michael E. Kelly, Niall J. O’Sullivan, Jarlath C. Bolger, Francesco Polignano, Haney Youssef, Andrew Renehan, Lee Malcomson, Sue Alves, Tom Cecil, Jürgen Mulsow, Brendan Moran, Faheez Mohamed, Ronan Cahill, Faraz Khan, Edward Murphy, Sanjeev Dayal, Connor Shields, Alexios Tzivanakis, Jonathan Wild. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry. British Journal of Cancer 2023; 128(1): 42 doi: 10.1038/s41416-022-02037-5
|
| 5 |
Fabio Carboni, Orietta Federici, Settimio Zazza, Francesco Corona, Fanny Massimi, Isabella Sperduti, Mario Valle. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal metastasis of non-primary origin. Langenbeck's Archives of Surgery 2021; 406(8): 2817 doi: 10.1007/s00423-021-02354-y
|
| 6 |
Wei Xia, Yiting Geng, Wenwei Hu. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer. Cancers 2023; 15(23): 5641 doi: 10.3390/cancers15235641
|
| 7 |
Mikkel Lundbech, Andreas Engel Krag, Lene Hjerrild Iversen, Anne-Mette Hvas. Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis. International Journal of Colorectal Disease 2022; 37(1): 17 doi: 10.1007/s00384-021-04021-6
|
| 8 |
Minsig Choi, Megan M. Harper, Prakash K. Pandalai, Sherif R. Z. Abdel-Misih, Reema A. Patel, Carleton S. Ellis, Ellen Reusch, Jeri Reynolds, Caterina Vacchi-Suzzi, Jinha M. Park, Georgios V. Georgakis, Joseph Kim. A Multicenter Phase 1 Trial Evaluating Nanoliposomal Irinotecan for Heated Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery for Patients with Peritoneal Surface Disease. Annals of Surgical Oncology 2023; 30(2): 804 doi: 10.1245/s10434-022-12723-6
|